Stemtech Corp (STEK) EBIT Margin (2021 - 2026)
Stemtech (STEK) posted EBIT Margin of 236.36% for Q1 2026, down 25.33% sequentially from 188.59% in Q4 2025, and down 9755.0% YoY from 2.45% in Q1 2025.
Stemtech Corp (STEK) EBIT Margin (2021 - 2026) Analysis & Trends
Stemtech has reported EBIT Margin for 6 years, with the latest figure at 236.36% in Q1 2026.
- Quarterly EBIT Margin fell 9755.0% year-over-year to 236.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 105.14% (down 4829.0% YoY) and the FY2025 annual result came in at 94.18%, down 4696.0% from the prior year.
- EBIT Margin eased to 236.36% in Q1 2026 per STEK's latest filing, from 188.59% in the prior quarter.
- Over five years, EBIT Margin peaked at 2.52% in Q4 2024 and troughed at 323.05% in Q3 2022.
- A 5-year average of 96.69% and a median of 73.11% in 2024 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin slumped 24201 bps in 2022, then soared 27845 bps in 2023.
- Over 5 years, EBIT Margin stood at 40.04% in 2022, then plunged by 162 bps to 104.79% in 2023, then soared by 102 bps to 2.52% in 2024, then tumbled by 7571 bps to 188.59% in 2025, then slipped by 25 bps to 236.36% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 236.36%, 188.59%, and 39.8% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -236.36% |
| Dec 31, 2025 | -188.59% |
| Sep 30, 2025 | -39.80% |
| Jun 30, 2025 | -43.13% |
| Mar 31, 2025 | -138.81% |
| Dec 31, 2024 | 2.52% |
| Sep 30, 2024 | -69.45% |
| Jun 30, 2024 | -52.22% |
| Mar 31, 2024 | -73.11% |
| Dec 31, 2023 | -104.79% |
| Sep 30, 2023 | -44.60% |
| Jun 30, 2023 | -85.77% |
| Mar 31, 2023 | -110.38% |
| Dec 31, 2022 | -40.04% |
| Sep 30, 2022 | -323.05% |
| Jun 30, 2022 | -80.55% |
| Mar 31, 2022 | -15.61% |
| Dec 31, 2021 | -138.76% |
| Sep 30, 2021 | -81.04% |
| Jun 30, 2021 | -56.41% |